EC Number   |
Inhibitors |
Structure  |
|---|
   3.2.1.106 | more |
- |
 |
| 3.2.1.106 | more |
no inhibition by 1 mM EDTA or 1 mM o-phenanthroline |
|
| 3.2.1.106 | more |
no inhibition by dithiothreitol, 2-mercaptoethanol, Mg2+, Mn2+, EDTA, potassium phosphate |
|
| 3.2.1.106 | more |
no inhibition by EDTA |
|
| 3.2.1.106 | more |
no inhibition by bromoconduritol |
|
| 3.2.1.106 | more |
inhibitors of processing glucosidase enhances anti CD3-induced interleukin-2 production and cause an accumulation of glucose-containing high-mannose-type oligosaccharides and suppress the secretion of interleukin-4, interferon-gamma and interleukin-5. Processing inhibitors inhibit the N-linked oligosaccharide processing of cytokines, inhibition of processing enzyme glucosidase I induces a decreased secretion of cytokines with N-linked oligosaccharides |
|
| 3.2.1.106 | more |
no inhibition by alpha- or beta-linked glucose disaccharides; no inhibition by methyl-beta-D-glucoside, sophorose laminaribiose, cellobiose, gentiobiose and methyl-alpha-D-glucoside |
|
| 3.2.1.106 | more |
no inhibition by alpha-1,3-, alpha-1,4-, and alpha-1,6-linked glucose disaccharides; no inhibition by EDTA; no inhibition by nigerose, maltose, isomaltose at 2 mM; no inhibition by swainsonine, deoxymannojirimycin or 1,4-dideoxy-1,4-imino-D-mannitol |
|
| 3.2.1.106 | more |
no inhibition by conduritol B epoxide, bromoconduritols a and B, acarbose at 1 mM |
|
| 3.2.1.106 | more |
no inhibition by 1-deoxymannojirimycin |
|
